2-氯-1-(3-氟-4-羟基苯基)-1-丙酮 | 86615-79-4

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 2-氯-1-(3-氟-4-羟基苯基)-1-丙酮
• 英文名称: 2-Chloro-1-(3-fluoro-4-hydroxyphenyl)propan-1-one
• CAS: 86615-79-4
• 化学式: C₉H₈ClFO₂
• 分子量: 202.613
• InChiKey: LDNNDSJVKVOANZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2-氯-1-(3-氟-4-羟基苯基)-1-丙酮 、 1-(3-羧苯基)-2-硫脲 以 乙醇 为溶剂， 生成 3-((4-(3-fluoro-4-hydroxyphenyl)-5-methylthiazol-2-yl)amino)benzoic acid
  参考文献：
  名称：

  Synthesis and in-vitro evaluation of 2-amino-4-arylthiazole as inhibitor of 3D polymerase against foot-and-mouth disease (FMD)

  摘要：

  Foot-and-mouth disease (FMD) is a highly contagious vesicular disease of livestock caused by a highly variable RNA virus, foot-and-mouth disease virus (FMDV). One of the targets to suppress expansion of and to control FMD is 3D polymerase (FMDV 3Dpol). In this study, 2-amino-4-arylthiazole derivatives were synthesized and evaluated for their inhibitory activity against FMDV 3Dpol. Among them, compound 20i exhibited the most potent functional inhibition (IC50 = 039 mu M) of FMDV 3D polymerase and compound 24a (EC50 = 13.09 mu M) showed more potent antiviral activity than ribavirin (EC50 = 1367 mu M) and T1105 (EC50 = 347 mu M) with IBRS-2 cells infected by the FMDV O/SKR/2010 strain. (C) 2015 Published by Elsevier Masson SAS.

  DOI：

  10.1016/j.ejmech.2015.08.020
• 作为产物：
  描述：

  1-(3-氟-4-羟基苯基)-1-丙酮 在 aluminum (III) chloride 、 丙酰氯 、 氯乙酰氯 作用下， 以 二硫化碳 为溶剂， 反应 10.0h， 生成 2-氯-1-(3-氟-4-羟基苯基)-1-丙酮
  参考文献：
  名称：

  Synthesis and in-vitro evaluation of 2-amino-4-arylthiazole as inhibitor of 3D polymerase against foot-and-mouth disease (FMD)

  摘要：

  Foot-and-mouth disease (FMD) is a highly contagious vesicular disease of livestock caused by a highly variable RNA virus, foot-and-mouth disease virus (FMDV). One of the targets to suppress expansion of and to control FMD is 3D polymerase (FMDV 3Dpol). In this study, 2-amino-4-arylthiazole derivatives were synthesized and evaluated for their inhibitory activity against FMDV 3Dpol. Among them, compound 20i exhibited the most potent functional inhibition (IC50 = 039 mu M) of FMDV 3D polymerase and compound 24a (EC50 = 13.09 mu M) showed more potent antiviral activity than ribavirin (EC50 = 1367 mu M) and T1105 (EC50 = 347 mu M) with IBRS-2 cells infected by the FMDV O/SKR/2010 strain. (C) 2015 Published by Elsevier Masson SAS.

  DOI：

  10.1016/j.ejmech.2015.08.020

文献信息

• Secondary phenylethanol amines, processes for their preparation and their pharmaceutical application
  申请人：BEECHAM GROUP PLC

  公开号：EP0070133A2

  公开（公告）日：1983-01-19

  Compounds of formula (I): and salts and in vivo hydrolysable acyl derivatives thereof, wherein R1 is hydrogen or methyl; R2 is hydrogen or methyl; R3 is phenyl unsubstituted or substituted with one or two of the following:- fluorine, chlorine, bromine, trifluoromethyl, C1-6 straight or branched chain alkyl or C1-6 straight or branched chain alkoxy; or is benzofuran-2-yl; R5 is a hydrogen, halogen, hydroxy, lower alkyl or lower alkoxy; R4 is moiety wherein X is C2-10 alkylene which may be straight or branched provided that the oxygen and nitrogen are separated by at least two carbon atoms, A is hydrogen; C1-6 straight or branched alkyl or benzyl optionally substituted with halogen, lower alkyl or lower alkoxy. R6 is hydrogen; C1-6 straight or branched alkyl; C1-6 straight or branched alkylsulphonyl R7 is C1-6 straight or branched alkyl; C1-6 straight or branched alkoxy; amino, mono- or di- (C1-6 straight or branched alkyl) amino; or is a 5,6 or 7 membered cyclic amine optionally containing a second hetero atom selected from oxygen, nitrogen and sulphur, and n is 1 or 2 have anti-obesity and anti-hyperglycaemic activity.

  式(I)化合物： 及其盐类和体内可水解酰基衍生物，其中 R1 是氢或甲基 R2 是氢或甲基 R3 是未取代的苯基或被下列一个或两个取代的苯基 氟、氯、溴、三氟甲基、C1-6 直链或支链烷基或 C1-6 直链或支链烷氧基；或苯并呋喃-2-基； R5 是氢、卤素、羟基、低级烷基或低级烷氧基； R4 是分子 其中 X 为 C2-10 亚烷基，可以是直链或支链亚烷基，条件是氧和氮至少相隔两个碳原子、 A 是氢；C1-6 直链或支链烷基或苄基，可选择被卤素、低级烷基或低级烷氧基取代。 R6 是氢；C1-6 直链或支链烷基；C1-6 直链或支链烷基磺酰基 R7 是 C1-6 直链或支链烷基；C1-6 直链或支链烷氧基；氨基，单-或二-（C1-6 直链或支链烷基）氨基；或 是 5、6 或 7 个成员的环胺，可选择含有选自氧、氮和硫的第二个杂原子、 且 n 为 1 或 2 的化合物具有抗肥胖和抗高血糖活性。
• Synthesis and in-vitro evaluation of 2-amino-4-arylthiazole as inhibitor of 3D polymerase against foot-and-mouth disease (FMD)
  作者：Kwi-wan Jeong、Jung-hun Lee、Sun-mi Park、Joo-Hyung Choi、Dae-Youn Jeong、Dong-Hwa Choi、Yeonju Nam、Jong-Hyeon Park、Kwang-Nyeong Lee、Su-Mi Kim、Jin-Mo Ku

  DOI：10.1016/j.ejmech.2015.08.020

  日期：2015.9

  Foot-and-mouth disease (FMD) is a highly contagious vesicular disease of livestock caused by a highly variable RNA virus, foot-and-mouth disease virus (FMDV). One of the targets to suppress expansion of and to control FMD is 3D polymerase (FMDV 3Dpol). In this study, 2-amino-4-arylthiazole derivatives were synthesized and evaluated for their inhibitory activity against FMDV 3Dpol. Among them, compound 20i exhibited the most potent functional inhibition (IC50 = 039 mu M) of FMDV 3D polymerase and compound 24a (EC50 = 13.09 mu M) showed more potent antiviral activity than ribavirin (EC50 = 1367 mu M) and T1105 (EC50 = 347 mu M) with IBRS-2 cells infected by the FMDV O/SKR/2010 strain. (C) 2015 Published by Elsevier Masson SAS.